CRSP Stock On Wild Ride After FDA's Historic Approval. These Gene Editing Treatments Could Be Next.
51:13
CRISPR 2.0, the Next Generation
1:05:45
How To Listen For Sell Signals And When To Stick To Your Hold Rules | Investing With IBD Podcast
8:40
¡Tu Microsoft Fabric es un desastre sin DOMINIOS!
48:03
El escándalo de los químicos eternos | Bloomberg Investigates
36:57
The Arcturus Therapeutics Story, mRNA and The Search for Transformative Medicines
47:54
Tale Of Two Markets: Are The Best Of Times Still Ahead? | SwingTrader Status Update
1:37:34
The Cancer Expert: "This Common Food Is Making Cancer Worse!"
1:00:12